These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3704065

  • 1. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
    Bagdy G, Rihmer Z, Frecska E, Szádóczky E, Arató M.
    Psychoneuroendocrinology; 1986; 11(1):117-20. PubMed ID: 3704065
    [Abstract] [Full Text] [Related]

  • 2. Monoamine oxidase and cortisol response in depression and schizophrenia.
    Pandey GN, Sharma RP, Janicak PG, Davis JM.
    Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
    [Abstract] [Full Text] [Related]

  • 3. Platelet MAO activity and the cortisol response to dexamethasone in major depression.
    Meltzer HY, Lowy MT, Locascio JJ.
    Biol Psychiatry; 1988 Jun; 24(2):129-42. PubMed ID: 3390495
    [Abstract] [Full Text] [Related]

  • 4. Platelet MAO activity and the dexamethasone suppression test in depressed patients.
    Schatzberg AF, Orsulak PJ, Rothschild AJ, Salomon MS, Lerbinger J, Kizuka PP, Cole JO, Schildkraut JJ.
    Am J Psychiatry; 1983 Sep; 140(9):1231-3. PubMed ID: 6614239
    [Abstract] [Full Text] [Related]

  • 5. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity.
    Schatzberg AF, Rothschild AJ, Gerson B, Lerbinger JE, Schildkraut JJ.
    Br J Psychiatry; 1985 Jun; 146():633-7. PubMed ID: 4016477
    [Abstract] [Full Text] [Related]

  • 6. Plasma cortisol, catecholamine and cyclic AMP levels, response to dexamethasone suppression test and platelet MAO activity in manic-depressive patients. A longitudinal study.
    Maj M, Ariano MG, Arena F, Kemali D.
    Neuropsychobiology; 1984 Jun; 11(3):168-73. PubMed ID: 6089030
    [Abstract] [Full Text] [Related]

  • 7. Platelet MAO activity in clinical subtypes of depression and DST suppression.
    Poirier MF, Lôo H, Mitrani N, Benkelfat C, Askienazy S, Le Fur G.
    Acta Psychiatr Scand; 1987 May; 75(5):456-63. PubMed ID: 3604729
    [Abstract] [Full Text] [Related]

  • 8. Classification of patients with affective disorders using platelet monoamine oxidase activity, serum melatonin and post-dexamethasone cortisol.
    Wahlund B, Sääf J, Wetterberg L.
    Acta Psychiatr Scand; 1995 May; 91(5):313-21. PubMed ID: 7639087
    [Abstract] [Full Text] [Related]

  • 9. Dexamethasone suppression test and sleep deprivation in endogenous depression.
    Kuhs H.
    J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
    [Abstract] [Full Text] [Related]

  • 10. The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression.
    Bloomingdale KL, Vasile RG, Gudeman JE, Gerson B, Schildkraut JJ.
    Biol Psychiatry; 1986 Apr; 21(4):390-3. PubMed ID: 3955113
    [No Abstract] [Full Text] [Related]

  • 11. Platelet MAO activity, TRH test, and dexamethasone suppression test in depressed patients.
    Loosen PT, Marciniak R.
    Pharmacopsychiatry; 1988 May; 21(3):131-5. PubMed ID: 3136464
    [Abstract] [Full Text] [Related]

  • 12. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder.
    Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH.
    Br J Psychiatry; 2004 Jun; 184():496-502. PubMed ID: 15172943
    [Abstract] [Full Text] [Related]

  • 13. The dexamethasone suppression test in a general hospital psychiatric setting.
    Warneke LB.
    Can J Psychiatry; 1985 Dec; 30(8):614-8. PubMed ID: 4084903
    [Abstract] [Full Text] [Related]

  • 14. Number of cortisol time-points and dexamethasone suppression test sensitivity for major depression.
    Extein I, Pottash AL, Gold MS.
    Psychoneuroendocrinology; 1985 Dec; 10(3):281-8. PubMed ID: 4059475
    [Abstract] [Full Text] [Related]

  • 15. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania.
    Swann AC, Stokes PE, Casper R, Secunda SK, Bowden CL, Berman N, Katz MM, Robins E.
    Acta Psychiatr Scand; 1992 Apr; 85(4):270-4. PubMed ID: 1595360
    [Abstract] [Full Text] [Related]

  • 16. Platelet monoamine oxidase in affective disorders.
    Edwards DJ, Spiker DG, Kupfer DJ, Foster G, Neil JF, Abrams L.
    Arch Gen Psychiatry; 1978 Dec; 35(12):1443-6. PubMed ID: 727880
    [Abstract] [Full Text] [Related]

  • 17. Age and the dexamethasone suppression test: results from a broad unselected patient population.
    Keitner GI, Ryan CE, Kohn R, Miller IW, Norman WH, Brown WA.
    Psychiatry Res; 1992 Oct; 44(1):9-20. PubMed ID: 1461951
    [Abstract] [Full Text] [Related]

  • 18. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E.
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [Abstract] [Full Text] [Related]

  • 19. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I.
    Biol Psychiatry; 1998 May 15; 43(10):762-6. PubMed ID: 9606531
    [Abstract] [Full Text] [Related]

  • 20. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.
    Arana GW, Wilens TE, Baldessarini RJ.
    Psychoneuroendocrinology; 1985 May 15; 10(1):49-60. PubMed ID: 4001277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.